Anti-Human CD172a Antibody (3F9) is a monoclonal inhibitory antibody targeting human CD172a (SIRPalpha), which can specifically recognize the transmembrane glycoprotein CD172a expressed on the surface of myeloid cells (monocytes, dendritic cells, macrophages, etc.).
Purity:
95.00%
Target:
Immunology/Inflammation related
T9901A-1934
* VAT and and shipping costs not included. Errors and price changes excepted